CYTOKINETICS INC 4

Robert E. Landry sold 1,000 shares of Cytokinetics, Inc. common stock at $74.66 per share on 2026-09-11.

On September 11, 2026, reporting person Robert E. Landry executed an open market sale of 1,000 shares of Cytokinetics, Inc. common stock at a price of $74.66 per share, for total proceeds of approximately $74,660. Following this transaction, Landry’s direct ownership in the company stands at 9,184 shares of common stock. The filing was submitted by attorney-in-fact John O. Faurescu on Landry’s behalf the same day, and no derivative securities or additional transactions were reported in this Form 4.

Filing Facts

CIK

1061983

Ticker

CYTK

Form

4

Source Type

fda

Accession

0001061983-26-000093

Alert Tier

5